The Ian Douglas Bebensee Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
1999
NCT02640300
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

clozapine (clozaril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1